Quadrant Biosciences is excited to share that Dr. Thomas Frazier II, PhD, will be joining our clinical advisory board. Dr Frazier is currently a Professor of Psychology at John Carroll University one of the leading researchers in the field of autism.

The first saliva test to accurately identify autism spectrum disorder (ASD) is now available throughout the United States. This test, called Clarifi ASD, is currently available to children 18 months through 6 years old with a clinical suspicion of autism. It’s not like other genetic tests on the market. Rather, this groundbreaking technology is...

Primary care physicians should play a greater role in the diagnosis of autism spectrum disorder, according to a recent research study. A group of health care professionals based out of Baylor College of Medicine and the University of Colorado College of Medicine published a study in Pediatrics called “Screening and Referral Practice for Autism...

Our company has successfully received a CPT® Proprietary Laboratory Analyses (PLA) Code from the American Medical Association for our autism saliva test, Clarifi ASD. This PLA code officially became effective on April 1, 2020.

Today kicks off the first day of Autism Awareness/Autism Acceptance Month. And we are so excited to once again honor it with the community.

The Center for Disease Control (CDC) now estimates the rate of autism spectrum disorder in the United States to be 1 in 54 children. This rise comes just two years after the CDC had announced the autism rate in the country to be 1 in 59 children. Experts say it’s the result of better early screening practices.

Last week we had the great privilege of being invited back to be interviewed Autism Live. During the webshow, we were able to discuss the recent launch of our autism saliva test, Clarifi ASD (some of you may recall our segment on the show last spring).

With the continued spread of COVID-19, families everywhere are taking precautions to stay healthy. But for families who have a child with autism, some of those basic precautions, like social distancing for example, may be especially stressful.

The Research Behind Clarifi ASD The Clarifi autism saliva test is based on years of peer-reviewed research. Quadrant Biosciences, the company behind the Clarifi autism saliva test, partnered with SUNY Upstate Medical University and Penn State Medical to develop this groundbreaking autism test.

For the first time in over a decade, the American Academy of Pediatrics (AAP) released a report updating their autism treatment guidelines. The goal? To help primary care physicians identify children at-risk for developmental delay sooner, so they can get access to beneficial services.

New Epigenetic Test for Autism- What Are Parents Thinking? If you know someone who has been through the autism diagnosis process, or if you have been through it yourself, you know it can be a long journey of searching for answers. From the point of first noticing early signs of autism to the actual diagnosis, the process can take years. While...

Clarifi Goes Back to the AAP We were excited to once again be a part of the American Academy of Pediatrics annual conference this past October. The conference brings in about 10,000 pediatric medical professionals from all over the globe interested in learning about the latest and best advances in healthcare for their patients. This year, we had...

Autism Saliva Test Aims to Reduce Age of Diagnosis Increasingly, more research is being published globally supporting the gut-brain connection theory and the important role of epigenetics and the microbiome in relation to autism spectrum disorder (ASD). In 2018, scientists discovered that certain molecules in the saliva, called non-coding RNAs,...

Early Intervention Makes A Difference Autism prevalence in the United States has been rising steadily over the years as awareness and understanding of the developmental disorder becomes better known. As of now, the Center for Disease Control and Prevention (CDC) estimates that 1 in 54 children are diagnosed with autism spectrum disorder. Other...